作者: Thomas Lion
DOI: 10.1182/BLOOD.V94.4.1486.416A37G_1486_1488
关键词:
摘要: To the Editor: In May 1, 1999 issue of Blood, Faderl et al[1][1] discuss possible clinical role polymerase chain reaction (PCR) analysis in surveillance residual disease patients with chronic myelogenous leukemia (CML). raise questions regarding